3M intends to spin off its healthcare business into a separate public company, in which 3M will retain a 19.9% stake. The approximately $8.6 billion company will specialize in wound care, medical information technology, oral care and biopharmaceutical filtration. 3M expects to complete the spin-off by the end of 2023.